DV Biomed Co., Ltd.

DV Biomed Co., Ltd.

TTPEX:6539
36.50
TWD
+0.05
(+0.14%)
1.01BMarket Cap
DV Biomed Co., Ltd.
TPEX:6539
(Taipei Exchange)

Recent

price

36.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
14.03
26.75
33.21
39.9
56.04
74.23
77.1
72.99
74.23
76.39
25.42
23.56
32.62
- -
Revenue per Share
1.61
3.89
8.31
7.7
7.67
5.74
6.64
12.14
12.37
11.51
6.69
3.66
0.32
- -
Basic EPS, GAAP
2.12
5.63
5.21
0.4
5.15
1.33
2.88
14.87
18.41
16.39
2.76
4.63
0.7
- -
Free Cash Flow per Basic Share
0.33
0.15
0.99
2.75
3.08
2.54
4.89
3.95
13.24
12.55
12.28
3.3
1.53
- -
Dividend per Share
4.45
16.38
25.01
29.84
34.3
38.06
40.79
48.89
47.88
26.15
19.57
64.92
20.84
22.57
Book Value per Share
4.41
16.35
24.66
29.6
34.11
37.21
40.26
48.7
47.66
26.04
19.53
64.42
20.74
22.49
Tangible Book Value per Share
9
16
25
25
25
25
25
25
25
24
24
24
24
24
Basic Weighted Avg Shares
131
417
830
1,003
1,409
1,866
1,930
1,812
1,827
1,866
619
574
794
- -
Sales/Revenue/Turnover
14.24
17.24
29.77
22.73
17.18
10.03
8.2
14.88
22.81
20.7
24.25
18.89
1.88
- -
Operating Margin (%)
9
17
33
39
48
66
182
179
183
184
25
19
35
- -
Depreciation Expense
15
61
207
194
193
144
166
301
305
281
163
89
8
- -
Net Income, GAAP
17.75
16.95
17
17.24
18.8
26.52
33.37
15.41
23.04
20.83
18.72
18.43
19.99
- -
Effective Tax Rate (%)
11.49
14.52
25.01
19.31
13.69
7.73
8.61
16.64
16.67
15.07
26.32
15.53
0.97
- -
Profit Margin (%)
78
299
483
550
579
697
656
543
589
470
330
418
351
400
Working Capital
- -
4
3
5
8
7
249
188
162
5
- -
100
30
22
LT Debt
112
412
629
750
862
1,122
1,217
1,204
1,179
637
476
534
507
550
Total Equity
- -
20.65
35.51
25.61
23.22
13.06
7.9
14.77
22.01
28.65
20.65
15.54
1.94
- -
Return on Invested Capital (%)
- -
21.46
37.47
27.39
23.73
16.52
17.79
21.49
21.56
27.79
32.83
13.57
1.47
- -
Return on Capital (%)
- -
23.13
39.89
28.1
23.93
15.85
16.78
27.04
25.57
30.98
29.27
17.63
1.49
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
14
16
15
LT Borrowings
- -
- -
- -
LT Finance Leases
34
30
22
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
1,455
1,437
1,010

Working Capital

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
488
489
544
Cash, Cash Equivalents & STI
317
328
359
Accounts Receivable, Net
34
30
35
Inventories
98
100
116
Total Current Liabilities
145
138
145
Payables & Accruals
- -
- -
- -
ST Debt
14
16
15
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.57%
-13.22%
-5.02%
Free Cash Flow
147.63%
-17.76%
-84.84%
Net Income, GAAP
-12.1%
-37.06%
-91.31%
Sales/Revenue/Turnover
5.84%
-6.54%
38.46%
Total Cash Common Dividend
34.35%
19.46%
-53.82%

Semi-annual Revenue

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
574
2025
- -
- -
794
2026
- -
- -
- -

Semi-annual Earnings Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.66
2025
- -
- -
0.32
2026
- -
- -
- -

Semi-annual Dividends Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.3
2025
- -
- -
1.53
2026
- -
- -
- -
Business
DV Biomed Co., Ltd. is a healthcare enterprise dedicated to the development and distribution of a diverse portfolio of health and beauty offerings across Taiwan, China, and global markets. Established in 2011 and headquartered in Taipei, Taiwan, the company specializes in producing and selling advanced medical-grade skincare solutions. Beyond direct manufacturing, it delivers health and weight management services, and functions as an authorized agent for various medical aesthetic fillers and specialized beauty equipment. Additionally, the firm provides an array of functional beverages and nutritional supplements designed for beauty, weight control, and overall wellness, complementing its extensive range of cosmetic goods and beauty treatment services. The company focuses on integrating research-driven innovation with consumer beauty needs, aiming to help customers achieve natural and elegant beauty.